Treatment of nail psoriasis with brodalumab: an open‐label unblinded study

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 35; no. 4; pp. e299 - e301
Main Authors Gregoriou, S., Tsiogka, A., Tsimpidakis, A., Nicolaidou, E., Kontochristopoulos, G., Rigopoulos, D.
Format Journal Article
LanguageEnglish
Published England 01.04.2021
Subjects
Antibodies, Monoclonal, Humanized
Humans
Nail Diseases - drug therapy
Psoriasis - drug therapy
Treatment Outcome
Online AccessGet full text
ISSN0926-9959
1468-3083
1468-3083
DOI10.1111/jdv.17055

Cover

Author Tsimpidakis, A.
Rigopoulos, D.
Tsiogka, A.
Nicolaidou, E.
Kontochristopoulos, G.
Gregoriou, S.
Author_xml – sequence: 1
  givenname: S.
  orcidid: 0000-0002-7585-1032
  surname: Gregoriou
  fullname: Gregoriou, S.
  organization: National and Kapodistrian University of Athens
– sequence: 2
  givenname: A.
  orcidid: 0000-0002-6853-9788
  surname: Tsiogka
  fullname: Tsiogka, A.
  email: a.tsiogka@yahoo.com
  organization: National and Kapodistrian University of Athens
– sequence: 3
  givenname: A.
  surname: Tsimpidakis
  fullname: Tsimpidakis, A.
  organization: National and Kapodistrian University of Athens
– sequence: 4
  givenname: E.
  orcidid: 0000-0002-8221-0217
  surname: Nicolaidou
  fullname: Nicolaidou, E.
  organization: National and Kapodistrian University of Athens
– sequence: 5
  givenname: G.
  surname: Kontochristopoulos
  fullname: Kontochristopoulos, G.
  organization: National and Kapodistrian University of Athens
– sequence: 6
  givenname: D.
  surname: Rigopoulos
  fullname: Rigopoulos, D.
  organization: National and Kapodistrian University of Athens
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33269501$$D View this record in MEDLINE/PubMed
BookMark eNp1kDtOxDAURS0EguFTsAHkEoqAHceOQ4f4o5FogNZy4hdh5NiDnYCmYwmskZUQmKFB8HSl15x7i7OJVn3wgNAuJYd0vKMn83JIS8L5CprQQsiMEclW0YRUuciqilcbaDOlJ0IIpVyuow3GclFxQidoehdB9x34HocWe20dnqUQrU424VfbP-I6BqPd0On6GGuPwwz8x9u70zU4PPjaWW_A4NQPZr6N1lrtEuws_xa6vzi_O73KpreX16cn06xhOecZr2QjdcOhbhiIXBYFEKNJBaVhJYhCtkXJqWxrIouv5EIYWjWkLmVbtlqzLbS_2J3F8DxA6lVnUwPOaQ9hSCovhChLxjgd0b0lOtQdGDWLttNxrn4MjMDRAmhiSClCqxrb694G38fRhqJEfTlWo2P17XhsHPxq_Iz-xS7XX62D-f-gujl7WDQ-AUz3i10
CitedBy_id crossref_primary_10_1159_000539727
crossref_primary_10_1016_j_ad_2022_01_032
crossref_primary_10_2147_CCID_S417679
crossref_primary_10_1159_000542568
crossref_primary_10_1007_s13555_021_00523_x
crossref_primary_10_1016_j_ad_2022_01_006
crossref_primary_10_1016_j_jaad_2023_11_024
crossref_primary_10_1007_s40257_023_00786_4
Cites_doi 10.1080/09546634.2018.1529381
10.1111/j.1365-2133.2008.08686.x
10.1111/j.1468-3083.2009.03453.x
10.1007/s40265-018-0888-4
10.1111/bjd.17351
10.1067/S0190-9622(03)00910-1
10.1080/09546634.2020.1749546
10.1016/j.jaad.2019.05.095
10.1159/000334482
ContentType Journal Article
Copyright 2020 European Academy of Dermatology and Venereology
Copyright_xml – notice: 2020 European Academy of Dermatology and Venereology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jdv.17055
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3083
EndPage e301
ExternalDocumentID 33269501
10_1111_jdv_17055
JDV17055
Genre letter
Letter
Clinical Trial
GroupedDBID ---
--K
.3N
.GA
.Y3
05W
0R~
10A
1B1
1OB
1OC
1~5
29L
31~
33P
36B
3SF
4.4
4G.
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AALRI
AAMNL
AANHP
AANLZ
AAONW
AAQFI
AAQXK
AASGY
AAXRX
AAXUO
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABQWH
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADZMN
AE3
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFTJW
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CO8
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FDB
FEDTE
FGOYB
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
NQ-
O66
O9-
OIG
OVD
OZT
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
R2-
RIG
RIWAO
RJQFR
ROL
RPZ
RX1
SAMSI
SEW
SUPJJ
TEORI
UB1
UHS
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
ACVFH
ADCNI
AEUPX
AEYWJ
AFPUW
AGHNM
AGQPQ
AGYGG
AIGII
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3255-598c8ac5ebc3e62844e0da09e7d37e648f47518fb0840840266d19c0b78f7faa3
IEDL.DBID DR2
ISSN 0926-9959
1468-3083
IngestDate Thu Jul 10 22:15:40 EDT 2025
Mon Jul 21 06:05:46 EDT 2025
Tue Jul 01 04:12:11 EDT 2025
Thu Apr 24 23:04:06 EDT 2025
Wed Jan 22 16:31:31 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3255-598c8ac5ebc3e62844e0da09e7d37e648f47518fb0840840266d19c0b78f7faa3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Correspondence-3
content type line 23
ORCID 0000-0002-7585-1032
0000-0002-6853-9788
0000-0002-8221-0217
PMID 33269501
PQID 2466773351
PQPubID 23479
PageCount 2
ParticipantIDs proquest_miscellaneous_2466773351
pubmed_primary_33269501
crossref_citationtrail_10_1111_jdv_17055
crossref_primary_10_1111_jdv_17055
wiley_primary_10_1111_jdv_17055_JDV17055
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2021
2021-04-00
2021-Apr
20210401
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: April 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of the European Academy of Dermatology and Venereology
PublicationTitleAlternate J Eur Acad Dermatol Venereol
PublicationYear 2021
References e_1_2_1_5_2_1
e_1_2_1_5_11_1
e_1_2_1_5_9_1
e_1_2_1_5_8_1
e_1_2_1_5_7_1
e_1_2_1_5_6_1
e_1_2_1_5_5_1
Reich K (e_1_2_1_5_10_1) 2020
e_1_2_1_5_4_1
e_1_2_1_5_3_1
References_xml – ident: e_1_2_1_5_9_1
  doi: 10.1080/09546634.2018.1529381
– ident: e_1_2_1_5_6_1
  doi: 10.1111/j.1365-2133.2008.08686.x
– ident: e_1_2_1_5_8_1
  doi: 10.1111/j.1468-3083.2009.03453.x
– ident: e_1_2_1_5_2_1
  doi: 10.1007/s40265-018-0888-4
– ident: e_1_2_1_5_5_1
  doi: 10.1111/bjd.17351
– ident: e_1_2_1_5_4_1
  doi: 10.1067/S0190-9622(03)00910-1
– ident: e_1_2_1_5_11_1
  doi: 10.1080/09546634.2020.1749546
– ident: e_1_2_1_5_3_1
  doi: 10.1016/j.jaad.2019.05.095
– year: 2020
  ident: e_1_2_1_5_10_1
  article-title: Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study
  publication-title: Br J Dermatol
– ident: e_1_2_1_5_7_1
  doi: 10.1159/000334482
SSID ssj0001158
Score 2.3597512
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e299
SubjectTerms Antibodies, Monoclonal, Humanized
Humans
Nail Diseases - drug therapy
Psoriasis - drug therapy
Treatment Outcome
Title Treatment of nail psoriasis with brodalumab: an open‐label unblinded study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdv.17055
https://www.ncbi.nlm.nih.gov/pubmed/33269501
https://www.proquest.com/docview/2466773351
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFB5KD-LFfakbo3joJSXJJJNET2ItpVgP0koPQpgtUAxJMU0PnvwJ_kZ_iTOTxR1EyCGQlyHJ2-e9fA-AU8G5LyLLNkRgckPlXwZ1HW74lnCljBBC9dC-4Q3uj53BxJ00wHn1L0yBD1FvuCnN0PZaKTih2Ucl54uOxoKR9tdCWOHmd2_foaNkpKOtcGBjQ2FqlahCuounuvOzL_oWYH6OV7XD6a2C--pRiz6Th04-px329AXF8Z_vsgZWykAUXhSSsw4aItkAS8Oy1L4JrkdVCzpMI5iQaQxnWSrFNZtmUO3eQiptL5G2jdAzSBKo5nC9Pr9IqRIxzBMaKyBGDjV-7RYY965Gl32jHL1gMCSTDMMNfOYT5grKkMDShTnC5MQMhMeRJ7DjR46q10TUlAmiPKSb51bATOr5kRcRgrZBM0kTsQtgRJAZeCzCPhZOQBixLMxs5nMPOcSiqAXaFRNCVuKSq_EYcVjnJ3wR6q_TAic16awA4_iJ6LjiZChVRdU_SCLSPAttB2PPQ8i1WmCnYHG9DJJhbOCa8kpbM-r39cNB906f7P2ddB8s26oXRnf8HIDm_DEXhzKYmdMjLbVvF7rwBw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JSsNAGP7RCurFfanrKB68pCSZZJKIF3GhautBqniRMFugGNJil4MnH8Fn9EmcmSR1BxFyCGQyJPn3Jd8PsCeFCGXiuJaMbGHp-Mtivies0JG-4hFKmRna17wi9Rvv4s6_G4PD8l-YHB9ilHDTkmH0tRZwnZD-KOViWDNgMOMwYepz2iW6fgePUr6O0cORSyyNqlXgCpk-nvLWz9bom4v52WM1JudsFu7Lh807TR5qgz6r8acvOI7_fZs5mCl8UXSUM888jMlsASabRbV9ERqtsgsddRKU0XaKur2O4theu4d0AhcxpX6pUm-UHSCaIT2K6_X5RTGWTNEgY6nGYhTIQNguwc3Zaeu4bhXTFyyOVZxh-VHIQ8p9yTiWRFkxT9qC2pEMBA4k8cLE0yWbhNkqRlSHsvTCibjNgjAJEkrxMlSyTiZXASUU21HAExIS6UWUU8ch3OWhCLBHHYarsF9SIeYFNLmekJHGoxBFDGPzdaqwO1razfE4flq0U5IyVtKiSyA0k51BL3Y9QoIAY9-pwkpO49E2WHmykW-rK_uGUr_vH1-c3JqTtb8v3YapeqvZiBvnV5frMO3q1hjTALQBlf7jQG4q36bPtgwLvwEcvvQl
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFH64gHhxX8Y1igcvHdomTVs9iTq4I6LiQShZQRw6gzPjwZM_wd_oLzFJ23EHEXooNA1t3_a95PV7ABtKykTpIPRU6kvP5l8ej4j0kkBFRkcY465p3-kZPbgiRzfRzQBsV__CFPwQ_QU3axnOX1sDb0v90cjlY91xwQzCMKEmTFpEdPHOHWWgjnPDaUg9S6pV0gq5Mp7q1s_B6BvC_AxYXcRpjMNt9axFocl9vdfldfH0hcbxny8zAWMlEkU7hepMwoDKp2DktNxrn4aTy6oGHbU0ytldE7U7LaOvnbsOssu3iBvny4xzY3wLsRzZRlyvzy9GrVQT9XLetEyMEjkC2xm4auxf7h54Ze8FT2CTZXhRmoiEiUhxgRU1MYwoXzI_VbHEsaIk0cRu2GjumwzRHCbOyyAVPo8THWvG8CwM5a1czQPSDPtpLDRNqCIpEywIqAhFImNMWMBxDTYrIWSiJCa3_TGaWT9BkY-Z-zo1WO8PbRdsHD8NWqskmRlbsRsgLFetXicLCaVxjHEU1GCuEHF_GmxwbBr55sqmE9Tv82dHe9fuZOHvQ1dh5HyvkZ0cnh0vwmho62Jc9c8SDHUfemrZAJsuX3EK_AZQhfLU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+nail+psoriasis+with+brodalumab%3A+an+open%E2%80%90label+unblinded+study&rft.jtitle=Journal+of+the+European+Academy+of+Dermatology+and+Venereology&rft.au=Gregoriou%2C+S.&rft.au=Tsiogka%2C+A.&rft.au=Tsimpidakis%2C+A.&rft.au=Nicolaidou%2C+E.&rft.date=2021-04-01&rft.issn=0926-9959&rft.eissn=1468-3083&rft.volume=35&rft.issue=4&rft.spage=e299&rft.epage=e301&rft_id=info:doi/10.1111%2Fjdv.17055&rft.externalDBID=10.1111%252Fjdv.17055&rft.externalDocID=JDV17055
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0926-9959&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0926-9959&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0926-9959&client=summon